Evaluation of the quality of prescriptions with antibiotics in the government hospitals of Yemen

Journal of Clinical and Diagnostic Research

Volumn 5, Issue 4, 2011, Pages 808-812

  Al Shami, Abdulkareem M ^a   Mohamed Izham, M I ^b   Abdo Rabbo, Ahmed ^c  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b QASSIM UNIVERSITY   (Saudi Arabia)

^c SANA A UNIVERSITY   (Yemen)

Author keywords

Antibiotics; Drug Utilization; Generic Medicines; Rational Prescribing; Yemen

Indexed keywords

ANTIBIOTIC AGENT;

ARTICLE; AWARENESS; CONTROLLED STUDY; DRUG INFORMATION; DRUG USE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE QUALITY; HUMAN; INAPPROPRIATE PRESCRIBING; MEDICAL PRACTICE; PHYSICIAN ATTITUDE; PRESCRIPTION; PROSPECTIVE STUDY; PUBLIC HOSPITAL; STRATEGIC PLANNING; YEMEN;

EID: 80051715538     PISSN: None     EISSN: 0973709X     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Abdo-Rabbo A. Misuse of Antibiotics in Yemen-a pilot study in the Aden governorate. Presented at the first international Middle East Conference on Pharmaceutical Sciences, Irbid-Jordon; 1993; 567-580.
2. Abdo-Rabbo A. Doctors' prescribing practices in outpatients departments in hospitals in Aden. J. Natural and Applied Sciences, University of Aden 1997; 1(2): 22-23.
3. Geest SV. et al Planning for essential drugs: are we missing the cultural dimension? Health Policy and Planning 1991; 5(2): 182-185.
4. Hogerzeil HV. Promoting rational prescribing: An International Perspective. British J. Clinical Pharmacy 1995; 39, 1-6.
5. WHO. How to investigate drug use in health facilities (selected drug use indicators). WHO/DAP/93.1. Geneva, World Health Organization; 1993; 456.
6. RPMPP. Rational Pharmaceutical Management Plus Program. How to Investigate Antimicrobial Drug Use in Hospitals: Selected Indicators. Draft published for the U.S. Agency for International Development by the Rational Pharmaceutical Management Plus Program. Arlington, VA: Management Sciences for Health; 2001; 776-790.
7. MoPH and P/NEDL. The National Essential Drugs List. General Directorate of Pharmaceutical Services and Medical Supplies, MoPH and P, Sanaà, Yemen; 1996; 389.
8. MoPH and P/NSTG. National Standard Treatment Guidelines. General Directorate of Pharmaceutical Services and Medical Supplies, MoPH and P, Sanaà, Yemen; 1996; 660-669.
9. Sachs L, Tomson G. Medicines and culture-a double perspective on drug utilization in a developing country, Soc Sci. Med 1992; 34(3): 307-315.
10. Abdo-Rabbo A. Baseline prescribing and health facility indicators in Yemen. Journal of Faculty of Medicine, Baghdad 2000; 42(4): 824-829.
11. Abdo-Rabbo A. Pilot base-line study of the RUD performance of health workers, an assessment of the prescribing practice in the districts of the Yemeni-German Health Sector Program (YG-HSP), November, Sanaà, Yemen; 2001; 389-400.
12. Bosu WK, Adjei, OD. An audit of the antibiotic prescribing practices in the health care facilities of west district of Ghana. J. West African Medical 2000; 19(4): 298-303.
13. Quick JD. Essential Medicines Twenty-Five Years On: Closing the Access Gap. Hospital Policy and Planning 2003; 18(1): 1-3.
14. Chareonkul et al. Rational Drug Use in Cambodia: A study of Three Pilot Health Centres in the Kampong Thom Province. South Asian J Trop Med Public Health 2002; 33(2): 418-424.
15. Saleh K. Malaysian Pharmaceutical Situation: Accessibility, Quality, Rational use and Evidence Based Evaluation, PhD Thesis, Universiti Sains Malaysia; 2004;230-242.
16. WHO. Drug Use Indicators in Magnolia. Essential Drugs and Medicine Policy. World Health Organization. May 2003; WPRO-EDM 2 (1), p. 4.
17. WHO. Progress of WHO Member States in Developing National Drug Polices and Revising Drugs List. WHO/DAP/98.7, 1998; 566.
18. Belongia EA. et al. Antibiotic Use and Upper Respiratory Infections: A survey of Knowledge, Attitude and Experience in Wisconsin and Minnesota. Preview Medicine 2002; 34(3): 346-352.
19. Dowell SF. Principles of the Judicious Use of Antimicrobial Agents for Paediatric Upper Respiratory Tract Infections. Paediatrics 1998; 101(1): 163-184.
20. Tan TQ et al. Penicillin-Resistant Systemic Pneumococcal Infections in Children: A Retrospective Case Control Study. Paediatrics 1993; 92:761-767.
21. Clavo-Sanchez AS. et al. Multivariate Analysis Risk Factors for Infection Due to Penicillin-Resistant and Multidrug Resistant Streptococcus Pneumonia Multicenter Study. Clin. Infect. Dis. 1997; 24:1052-1059.
22. Dowell SF, Schwartz BS. Protecting patients through the judicious use of antibiotics. American Family Physician. 1997; 55:1647-1654.
23. SBDMA. Annual Statistical Report-2002. Supreme Board of Drugs and Medical Appliances, MoPH and P, Sana' a, Yemen; 2002; 234.
24. SBDMA. (2003) Annual Statistical Report-2003. Supreme Board of Drugs and Medical Appliances, MoPH and P, Sana' a, Yemen; 2003 456-457.
25. Quick J et al. Interventional research to promote the clinically effective and economically efficient use of pharmaceuticals: the international network for the rational use of drugs. J. Clinical Epidemiology 1991; 44(12): 57-65.
26. WHO. Suntik, ya? Investigating Popular Demand for Injections in Indonesia and Uganda. Essential Drugs Monitor. World Health Organization, 1997; (23). P.15.
27. Abdo-Rabbo A. Patients' care regarding consultation and dispensing in some of the public hospitals and private clinics in Sana'a. INRUD News, 1995; 2(5): 22-23.